Modified reverse transcriptases
    1.
    发明授权

    公开(公告)号:US12221633B2

    公开(公告)日:2025-02-11

    申请号:US18348544

    申请日:2023-07-07

    Abstract: The present disclosure provides methods and systems for amplifying and analyzing nucleic acid samples. The present disclosure provides methods for preparing cDNA and/or DNA molecules and cDNA and/or DNA libraries using modified reverse transcriptases.

    Methods of cDNA preparation
    5.
    发明授权

    公开(公告)号:US12221634B2

    公开(公告)日:2025-02-11

    申请号:US18449107

    申请日:2023-08-14

    Abstract: The present disclosure provides methods and systems for amplifying and analyzing nucleic acid samples. The present disclosure provides methods for preparing cDNA and/or DNA molecules and cDNA and/or DNA libraries using modified reverse transcriptases.

    Method and system for sampling material from cells

    公开(公告)号:US11542541B2

    公开(公告)日:2023-01-03

    申请号:US17105333

    申请日:2020-11-25

    Abstract: Methods, systems, and devices for sampling/isolating material from cells. An exemplary system may comprise a chip including an electrode array of sampling electrodes arranged along a surface of the chip. A cell-receiving area may be located adjacent the surface of the chip. The system also may comprise a tag array of tags supported by the chip and aligned with the electrode array. Each tag of the tag array may include an identifier that is unique to the tag within the tag array. Each tag may be configured to bind nucleic acids, or a capturing agent distinct from the tag may be aligned with each sampling electrode of the electrode array to capture a protein or other analyte of interest. The system further may comprise a control circuit configured to apply an individually controllable voltage to each sampling electrode of the electrode array and measure an electrical property of the sampling electrode.

    HYBRID REVERSE TRANSCRIPTASES
    10.
    发明申请

    公开(公告)号:US20210017504A1

    公开(公告)日:2021-01-21

    申请号:US16928915

    申请日:2020-07-14

    Abstract: Hybrid reverse transcriptases are provided that comprise a non-retroviral retrotransposon, or a fragment of the non-retroviral retrotransposon having reverse transcriptase activity, joined to a nucleic acid binding protein. Also provided are methods of using the hybrid reverse transcriptases to prepare a cDNA molecule library.

Patent Agency Ranking